Day 1 :
Keynote Forum
Ruchin Kansal
Board of Directors at Stanford Medicine X and Executive Advisor at Healthspottr, USA
Keynote: Transformative Leadership in the era of Artificial Intelligence in the Healthcare industry
Time : 10.00 AM-10.30 AM
Biography:
The keynote explains why “not taking chances is not an option” for individuals and companies that are looking to stay competitive and survive for the long term. Enabling leaders to win the innovation challenge presented in the 2020 decade is of utmost importance for the future of the Healthcare industry. It requires transformative leadership to lead, manage and channel pattern-interrupt breakthroughs like Artificial Intelligence.
Abstract:
Robert Jamison is a Professor at Harvard Medical School with appointments in the Departments of Anesthesiology, Perioperative and Pain Medicine, Psychiatry, and Physical Medicine and Rehabilitation. His professional time is spent teaching and actively engaging in research. His recent research has focused on the examination of predictors of opioid abuse in chronic pain patients, patient engagement using telemedicine, and numerous clinical trials funded by the NIH and industry. He has been Research Mentor to several attending physicians and graduate students at Harvard and other Institutions. He also has assisted the coordination of clinical research within the Pain Trials Center at Brigham and Women’s Hospital. He has been Principal Investigator on several NIH-funded projects. He is currently a Member of five scientific journal Editorial Boards. He has authored two books, and over 300 peer-reviewed articles, chapters, and abstracts in the areas of Innovative Technology, Behavioral Medicine and Chronic Pain. He has been active and held board positions in many regional, national, and international organizations such as the American Pain Society and the International Association for the Study of Pain. He has been the Past President of the New England Pain Association and has served on the Executive Committee and Board of Directors of the American Pain Society. He is committed to the Clinician Teacher/Trainer Model and is a very important Figure in Clinical Research.
- Healthcare IT and Digital Health | Health Care Statistics and Research | Healthcare | Internal Medicine and Primary Care | Medical Sociology and Public Health | Healthcare Technologies | Public Health Nutrition | Health Informatics
Location: Hall 1
Session Introduction
Sergey Suchkov
Sechenov University , Russia
Title: The keynote explains why “not taking chances is not an option†for individuals and companies that are looking to stay competitive and survive for the long term. Enabling leaders to win the innovation challenge presented in the 2020 decade is of utmost importance for the future of the Healthcare industry. It requires transformative leadership to lead, manage and channel pattern-interrupt breakthroughs like Artificial Intelligence.
Biography:
Sergey Suchkov was born in the City of Astrakhan, Russia, in a family of dynasty medical doctors. In 1980, graduated from Astrakhan State Medical University and was awarded with MD. In 1985, Suchkov maintained his PhD as a PhD student of the I.M. Sechenov Moscow Medical Academy and Institute of Medical Enzymology. In 2001, Suchkov maintained his Doctor Degree at the National Institute of Immunology, Russia.
Abstract:
A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the subclinical recognition of biomarkers of hidden abnormalities long before the disease clinically manifests itself.
Each decision-maker values the impact of their decision to use PPM on their own budget and well-being, which may not necessarily be optimal for society as a whole. It would be extremely useful to integrate data harvesting from different databanks for applications such as prediction and personalization of further treatment to thus provide more tailored measures for the patients resulting in improved patient outcomes, reduced adverse events, and more cost effective use of the latest health care resources including diagnostic (companion ones), preventive and therapeutic (targeted molecular and cellular) etc. A lack of medical guidelines has been identified by responders as the predominant barrier for adoption, indicating a need for the development of best practices and guidelines to support the implementation of PPM! Implementation of PPM requires a lot before the current model “physician-patient” could be gradually displaced by a new model “medical advisor-healthy person-at-risk”. This is the reason for developing global scientific, clinical, social, and educational projects in the area of PPM to elicit the content of the new branch.
Gavin S. Lew
Managing Partner, Bold Insight Inc, USA
Title: The Time is Now for Healthcare and AI: Don't leave it up to the programmers
Biography:
Gavin is Managing Director of Bold Insight, a full-service UX research agency that is globally funded, employee owned, and based in Chicago with global offices in 5 countries. He has 25 years of experience, working in both corporate and academic environments. Gavin founded the UX consultancy User Centric in 1999, growing it to become the largest, private UX consultancy in the US. After selling the company, he continued to lead the North American UX team, which become one of the most profitable business units of its parent organization. Gavin then founded Bold Insight. He is a frequent presenter at national and international conferences and inventor on several patents. He is an adjunct professor at DePaul and Northwestern Universities and a guest lecturer at University of California, San Diego’s Design Lab. Gavin has an MA in Experimental Psychology from Loyola University.
Abstract:
“We built it, because we could” is a common theme in the world of tech and in many cases, engineers and developers create because they wanted to see what could happen. Artificial Intelligence (AI) is following the same path in healthcare In this presentation, Gavin will discuss core elements from a book he is co-writing on AI. The foundation for concern will be described as a call to arms so those in healthcare do not sit back and wait for AI to take shape. Now is the time for us to take an active role in embedding AI into products.
Vlad Mkrtumyan
Serial entrepreneur, search engine marketing evangelist and a passionate networker, USA
Title: SEO For Doctors: The Challenges & Tactics to Address in 2020
Biography:
Vlad Mkrtumyan is a serial entrepreneur, search engine marketing evangelist and a passionate networker, responsible for running five meetups including the Seattle Marketing and Demand Leaders Meetup – the largest marketing meetup in Seattle.Vlad began his entrepreneurial odyssey as a teenager, when he launched the Shoplletes app which went on to have 30,000 active monthly users and 300,000 downloads on the Google Play Store. Just a few years after his first venture, Vlad started Skyreal, a real estate recruitment CRM for fast growing brokerages, growing to 13 brokerages across three states.
Abstract:
This sessions goal is to demonstrate successful & reproducible tactics that will increase search traffic, conversions, & improve your rankings in Google. Looking at our campaigns & experiments in 2019, we'll review examples of SEO tactics that have increased rankings, how much traffic improvement was seeing over 3, 6, and 12 month timelines. I will present the processes and documentation we used so that attendees can replicate and perform the work independently with their teams as they are able. This session will be targeted to those with mid-tier knowledge of SEO who want to increase results
Reynand F. Dumala-on
Essex, England, United Kingdom
Title: Anti-hyperglycemic Potency of Asthma Weed (Euphorbia hirta Linn.) Leaves Crude Extract in Female White Mice
Biography:
Reynand F. Dumala-on is currently Working at Essex, England
Abstract:
Asthma Weed (Euphorbia hirta Linn.) is an endemic plant species that is rich in phytochemicals which may offer potent cure for diseases especially in treating hyperglycemia. This experimental study was conducted to evaluate the anti-hyperglycemic potency of Asthma Weed (Euphorbia hirta Linn.) leaves crude extract in blood glucose level of female white mice (Mus musculus).
Biography:
ZANERA NAWAZ (Author), ISABELLA NYAMBAYO (Supervisor) and Sarah Forbes Robertson
Abstract:
Bitterness is natural taste component which protects us from consumption of plant toxins. G-protein-coupled receptors (GPCRs) bind with bitter substance like Phenylthiocarbamide (PTC) and transmit signals to the brain where flavour perceived. Three SNPs of TAS2R38 gene are responsible for individual’s ability to taste bitter compound. This study design was a questionnaire and Laboratory based study.